Byondis Appoints Christoph Korpus CEO, Founder Jacques Lemmens Becomes Chairman
Byondis B.V., an independent biopharmaceutical company creating innovative targeted medicines for patients with cancer, recently announced the appointment of Christoph Korpus, PhD, MBA, as Chief Executive Officer (CEO), effective immediately. Christoph has served as Chief Business Officer (CBO) of the Company since January 2025. He succeeds Byondis Founder and former CEO Jacques Lemmens, PhD, who […]
